| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |